Ispecimen.com

Site Inspections

Overview & More informations

iSpecimen is a global marketplace for human biospecimens and data. The company connects researchers with patients who are willing to donate their biospecimens and data for medical research. iSpecimen's platform enables researchers to search for and request biospecimens and data from a global network of biobanks and hospitals. The company also provides services to help researchers design and manage their research studies.

iSpecimen was founded in 2012 by Christopher Mason, a geneticist and entrepreneur. The company is headquartered in San Francisco, California. iSpecimen has raised over $100 million in funding from investors including Google Ventures, Khosla Ventures, and Stanford University.

iSpecimen's platform is used by researchers from around the world to conduct a wide range of medical research studies. The company's biospecimens and data have been used to study a variety of diseases, including cancer, Alzheimer's disease, and Parkinson's disease. iSpecimen has also been used to develop new drugs and treatments.

The company has been praised for its innovative approach to medical research. However, iSpecimen has also been criticized for its lack of transparency about the sources of its biospecimens and data. Some critics have also raised concerns about the company's business model, which profits from the sale of human biospecimens and data.

Domains Expiration Date Updated